Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy

Objective. While 6- to 12-month courses of isoniazid for tuberculosis prevention are considered safe in pregnant women, the effects of longer-term isoniazid prophylaxis or isoniazid in combination with antiretroviral therapy (ART) are not established in human-immunodeficiency-virus-(HIV-) infected w...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Allan W., Mosimaneotsile, Barudi, Mathebula, Unami, Mathoma, Anikie, Moathlodi, Ritah, Theebetsile, Irene, Samandari, Taraz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606726/
https://www.ncbi.nlm.nih.gov/pubmed/23533318
http://dx.doi.org/10.1155/2013/195637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606726/
https://www.ncbi.nlm.nih.gov/pubmed/23533318
http://dx.doi.org/10.1155/2013/195637

Ejemplares similares